OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
Xuewei Zheng, Haodi Ma, Jingjing Wang, et al.
Translational Oncology (2022) Vol. 26, pp. 101534-101534
Open Access | Times Cited: 27
Xuewei Zheng, Haodi Ma, Jingjing Wang, et al.
Translational Oncology (2022) Vol. 26, pp. 101534-101534
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 234-234
Open Access | Times Cited: 1
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 234-234
Open Access | Times Cited: 1
Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells
Sama W.A. Helmy, Amal Kamal Abdel‐Aziz, Eman M.E. Dokla, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116255-116255
Closed Access | Times Cited: 7
Sama W.A. Helmy, Amal Kamal Abdel‐Aziz, Eman M.E. Dokla, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116255-116255
Closed Access | Times Cited: 7
The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatment
Qinan Yin, Haodi Ma, Yirui Dong, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Qinan Yin, Haodi Ma, Yirui Dong, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: a retrospective longitudinal study
Zhihao Fang, Guohong Ren, Shouyu Ke, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Zhihao Fang, Guohong Ren, Shouyu Ke, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Haodi Ma, Yirui Dong, Jiayu Zheng, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access
Metabolomic Profiling of Disease Progression Following Radiotherapy for Breast Cancer
Alexandra N. McMahon, Isildinha M. Reis, Cristiane Takita, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 891-891
Open Access
Alexandra N. McMahon, Isildinha M. Reis, Cristiane Takita, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 891-891
Open Access
Cell Progression and Survival Functions of Enzymes Secreted in Extracellular Vesicles Associated with Breast and Prostate Cancers
Cosmos Ifeanyi Onyiba, Namita Kumar, Christopher J. Scarlett, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 468-468
Open Access
Cosmos Ifeanyi Onyiba, Namita Kumar, Christopher J. Scarlett, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 468-468
Open Access
Patient-derived organotypic tissue cultures as a platform to evaluate metabolic reprogramming in breast cancer patients
Teresa W.‐M. Fan, Jing Yan, Carlos Frederico Lima Gonçalves, et al.
Journal of Biological Chemistry (2025), pp. 108495-108495
Open Access
Teresa W.‐M. Fan, Jing Yan, Carlos Frederico Lima Gonçalves, et al.
Journal of Biological Chemistry (2025), pp. 108495-108495
Open Access
Immune-related biomarkers predict the prognosis and immune response of breast cancer based on bioinformatic analysis and machine learning
Xuewei Zheng, Haodi Ma, Yirui Dong, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 12
Xuewei Zheng, Haodi Ma, Yirui Dong, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 12
Liver X Receptor Ligand GAC0001E5 Downregulates Antioxidant Capacity and ERBB2/HER2 Expression in HER2-Positive Breast Cancer Cells
Asitha Premaratne, Shinjini Basu, Abhinav Bagchi, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1651-1651
Open Access | Times Cited: 4
Asitha Premaratne, Shinjini Basu, Abhinav Bagchi, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1651-1651
Open Access | Times Cited: 4
Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer
Amalia Kotsifaki, Sousanna Maroulaki, Efthymios Karalexis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9302-9302
Open Access | Times Cited: 4
Amalia Kotsifaki, Sousanna Maroulaki, Efthymios Karalexis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9302-9302
Open Access | Times Cited: 4
Dual inhibitor of MDM2 and NFAT1 for experimental therapy of breast cancer: in vitro and in vivo anticancer activities and newly discovered effects on cancer metabolic pathways
Wei Wang, Mariela C Aguilar, Sayantap Datta, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Wei Wang, Mariela C Aguilar, Sayantap Datta, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Biological Basis of Breast Cancer-Related Disparities in Precision Oncology Era
Anca-Narcisa Neagu, Pathea Bruno, Kaya R. Johnson, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4113-4113
Open Access | Times Cited: 2
Anca-Narcisa Neagu, Pathea Bruno, Kaya R. Johnson, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4113-4113
Open Access | Times Cited: 2
Free Salivary Amino Acid Profile in Breast Cancer: Clinicopathological and Molecular Biological Features
Lyudmila V. Bel’skaya, Elena A. Sarf, Denis V. Solomatin
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5614-5631
Open Access | Times Cited: 2
Lyudmila V. Bel’skaya, Elena A. Sarf, Denis V. Solomatin
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5614-5631
Open Access | Times Cited: 2
Replenishment of TCA cycle intermediates and long-noncoding RNAs regulation in breast cancer
Xuewei Zheng, Shunshun Zhang, Haodi Ma, et al.
Molecular and Cellular Endocrinology (2024) Vol. 592, pp. 112321-112321
Closed Access | Times Cited: 1
Xuewei Zheng, Shunshun Zhang, Haodi Ma, et al.
Molecular and Cellular Endocrinology (2024) Vol. 592, pp. 112321-112321
Closed Access | Times Cited: 1
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer
Chiara Papulino, Ugo Chianese, Ahmad H. Ali, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Chiara Papulino, Ugo Chianese, Ahmad H. Ali, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
NUAKs promote mTOR/c-Myc-induced glucose and glutamine reprogramming for cell growth and metastasis in breast cancer cells
Acily Skadon Worral Wilfred Raj, Ravi Manoharan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 1, pp. 167508-167508
Closed Access | Times Cited: 1
Acily Skadon Worral Wilfred Raj, Ravi Manoharan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 1, pp. 167508-167508
Closed Access | Times Cited: 1
Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Revealed the Molecular Targets and Potential Mechanism of Nauclea Latifolia in the Treatment of Breast Cancer.
Cromwel Tepap Zemnou
Chemistry & Biodiversity (2024)
Closed Access | Times Cited: 1
Cromwel Tepap Zemnou
Chemistry & Biodiversity (2024)
Closed Access | Times Cited: 1
Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation
Eun‐Ryeong Hahm, Su‐Hyeong Kim, Subrata K. Pore, et al.
Molecular Carcinogenesis (2023) Vol. 63, Iss. 2, pp. 301-313
Closed Access | Times Cited: 2
Eun‐Ryeong Hahm, Su‐Hyeong Kim, Subrata K. Pore, et al.
Molecular Carcinogenesis (2023) Vol. 63, Iss. 2, pp. 301-313
Closed Access | Times Cited: 2
High Glycolytic Activity Signature Reveals CCNB2 as a Key Therapeutic Target in Triple-Negative Breast Cancer
Jing Liang, Haodi Ma, Shunshun Zhang, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access
Jing Liang, Haodi Ma, Shunshun Zhang, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access
Impact of Physical Activity on DNA Methylation Signatures in Breast Cancer Patients: A Systematic Review with Bioinformatic Analysis
Chantalle Moulton, Veronica Lisi, Monica Silvestri, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3067-3067
Open Access
Chantalle Moulton, Veronica Lisi, Monica Silvestri, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3067-3067
Open Access
On Digital Breast Tomosynthesis and Mammography with Contrast Medium: Notes on Molecular Breast Imaging
Cristina Poggi
(2024), pp. 171-184
Closed Access
Cristina Poggi
(2024), pp. 171-184
Closed Access
Advanced machine learning unveils CD8 + T cell genetic markers enhancing prognosis and immunotherapy efficacy in breast cancer
Haodi Ma, Linlin Shi, Jiayu Zheng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Haodi Ma, Linlin Shi, Jiayu Zheng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
In-silico identification and validation of Silibinin as a dual inhibitor for ENO1 and GLUT4 to curtail EMT signaling and TNBC progression
Dheepika Venkatesh, Shilpi Sarkar, Thirukumaran Kandasamy, et al.
Computational Biology and Chemistry (2024) Vol. 115, pp. 108312-108312
Closed Access
Dheepika Venkatesh, Shilpi Sarkar, Thirukumaran Kandasamy, et al.
Computational Biology and Chemistry (2024) Vol. 115, pp. 108312-108312
Closed Access
Genetic heterogeneity and metabolic reprogramming in breast cancer
Yarkın Dolaş, Ayşe Buruş, Başak Çeltikçi
Acta Medica (2024) Vol. 55, Iss. 4, pp. 227-246
Open Access
Yarkın Dolaş, Ayşe Buruş, Başak Çeltikçi
Acta Medica (2024) Vol. 55, Iss. 4, pp. 227-246
Open Access
